BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30536377)

  • 1. Loss of Lgr4 inhibits differentiation, migration and apoptosis, and promotes proliferation in bone mesenchymal stem cells.
    Sun P; Jia K; Zheng C; Zhu X; Li J; He L; Siwko S; Xue F; Liu M; Luo J
    J Cell Physiol; 2019 Jul; 234(7):10855-10867. PubMed ID: 30536377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix remodeling associated 7 promotes differentiation of bone marrow mesenchymal stem cells toward osteoblasts.
    Zhou Z; Shen Y; Yin J; Xi F; Xu R; Lin D; Saijilafu ; Chen J; Wang Y
    J Cell Physiol; 2019 Aug; 234(10):18053-18064. PubMed ID: 30843215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexras1 plays a pivotal role in maintaining the equilibrium between adipogenesis and osteogenesis.
    Seok JW; Kim D; Yoon BK; Lee Y; Kim HJ; Hwang N; Fang S; Kim HJ; Kim JW
    Metabolism; 2020 Jul; 108():154250. PubMed ID: 32335074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rspo1-LGR4 axis in BMSCs protects bone against radiation-induced injury through the mTOR-dependent autophagy pathway.
    Chen X; Chen L; Tan J; Zhang L; Xia J; Cheng B; Zhang W
    J Cell Physiol; 2021 Jun; 236(6):4273-4289. PubMed ID: 33452710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity.
    Lee NJ; Doyle KL; Sainsbury A; Enriquez RF; Hort YJ; Riepler SJ; Baldock PA; Herzog H
    J Bone Miner Res; 2010 Aug; 25(8):1736-47. PubMed ID: 20200977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scara3 regulates bone marrow mesenchymal stem cell fate switch between osteoblasts and adipocytes by promoting Foxo1.
    Chen P; Hu B; Xie LQ; Jiang TJ; Xia ZY; Peng H
    Cell Prolif; 2021 Aug; 54(8):e13095. PubMed ID: 34254370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of CDC20 promotes adipogenesis of bone marrow-derived stem cells by modulating β-catenin.
    Du Y; Liu Y; Zhou Y; Zhang P
    Stem Cell Res Ther; 2022 Sep; 13(1):443. PubMed ID: 36056439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin Receptor Promotes Adipogenesis and Reduces Osteogenesis by Regulating Mesenchymal Stromal Cells in Adult Bone Marrow.
    Yue R; Zhou BO; Shimada IS; Zhao Z; Morrison SJ
    Cell Stem Cell; 2016 Jun; 18(6):782-796. PubMed ID: 27053299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interferon-inducible protein p202 promotes osteogenesis in mouse bone marrow stromal cells.
    Zhang L; Wang C; Zhang X; Li H
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29853536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-130a controls bone marrow mesenchymal stem cell differentiation towards the osteoblastic and adipogenic fate.
    Lin Z; He H; Wang M; Liang J
    Cell Prolif; 2019 Nov; 52(6):e12688. PubMed ID: 31557368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAF3, a Target of MicroRNA-363-3p, Suppresses Senescence and Regulates the Balance Between Osteoblastic and Adipocytic Differentiation of Rat Bone Marrow-Derived Mesenchymal Stem Cells.
    Wang D; Cai G; Wang H; He J
    Stem Cells Dev; 2020 Jun; 29(11):737-745. PubMed ID: 32111144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of LGR4 inhibits proliferation and odonto/osteogenic differentiation of stem cells from apical papillae.
    Zhou M; Guo S; Yuan L; Zhang Y; Zhang M; Chen H; Lu M; Yang J; Ma J
    J Mol Histol; 2017 Dec; 48(5-6):389-401. PubMed ID: 28986711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-cadherin/wnt interaction controls bone marrow mesenchymal cell fate and bone mass during aging.
    Haÿ E; Dieudonné FX; Saidak Z; Marty C; Brun J; Da Nascimento S; Sonnet P; Marie PJ
    J Cell Physiol; 2014 Nov; 229(11):1765-75. PubMed ID: 24664975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [(*)AG490 could suppress bone marrow mesenchymal stem cells migration, mineralization and bone defect healing via inhibiting Jak2-STAT3 pathway].
    Yu X; Wan QL; Li Z; Li ZB
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 May; 53(5):293-300. PubMed ID: 29972985
    [No Abstract]   [Full Text] [Related]  

  • 15. Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells.
    Xiao L; Sobue T; Esliger A; Kronenberg MS; Coffin JD; Doetschman T; Hurley MM
    Bone; 2010 Aug; 47(2):360-70. PubMed ID: 20510392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The optimal time to inject bone mesenchymal stem cells for fracture healing in a murine model.
    Wang X; Wang C; Gou W; Xu X; Wang Y; Wang A; Xu W; Guo Q; Liu S; Lu Q; Meng H; Yuan M; Peng J; Lu S
    Stem Cell Res Ther; 2018 Oct; 9(1):272. PubMed ID: 30359311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marrow adipocytes inhibit the differentiation of mesenchymal stem cells into osteoblasts via suppressing BMP-signaling.
    Abdallah BM
    J Biomed Sci; 2017 Feb; 24(1):11. PubMed ID: 28173811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA Bmncr regulates mesenchymal stem cell fate during skeletal aging.
    Li CJ; Xiao Y; Yang M; Su T; Sun X; Guo Q; Huang Y; Luo XH
    J Clin Invest; 2018 Dec; 128(12):5251-5266. PubMed ID: 30352426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spleen tyrosine kinase influences the early stages of multilineage differentiation of bone marrow stromal cell lines by regulating phospholipase C gamma activities.
    Kusuyama J; Kamisono A; ChangHwan S; Amir MS; Bandow K; Eiraku N; Ohnishi T; Matsuguchi T
    J Cell Physiol; 2018 Mar; 233(3):2549-2559. PubMed ID: 28786489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptomics comparison between porcine adipose and bone marrow mesenchymal stem cells during in vitro osteogenic and adipogenic differentiation.
    Monaco E; Bionaz M; Rodriguez-Zas S; Hurley WL; Wheeler MB
    PLoS One; 2012; 7(3):e32481. PubMed ID: 22412878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.